Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.

about

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment.Metabolism and transport of oxazaphosphorines and the clinical implications.

P2860

Q35079602-D70057DF-F9D3-4E8C-8044-CE14E7B6EEA2 Q36360811-DB25E85D-D90D-49F5-9327-EE0D0CC4D467

P2860

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.

Item

http://www.wikidata.org/entity/Q43848133

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@en

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@nl

type

Item

label

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@en

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@nl

prefLabel

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@en

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@nl

P1476

Phase II trial of high-dose in ...... ding recurrent ovarian cancer.

@en

P2093

Alvarnas J

http://www.w3.org/2001/XMLSchema#string

Chow W

http://www.w3.org/2001/XMLSchema#string

Doroshow JH

http://www.w3.org/2001/XMLSchema#string

Forman S

http://www.w3.org/2001/XMLSchema#string

Hamasaki V

http://www.w3.org/2001/XMLSchema#string

Leong L

http://www.w3.org/2001/XMLSchema#string

Margolin K

http://www.w3.org/2001/XMLSchema#string

McGonigle K

http://www.w3.org/2001/XMLSchema#string

McNamara M

http://www.w3.org/2001/XMLSchema#string

Morgan RJ

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

The role of chemotherapy in the management of celomic epithelial carcinoma of the ovary.

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.

Impact of doxorubicin on survival in advanced ovarian cancer.

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.

P2888

sj.bmt.1703243

P304

859-863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1703243

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeff Longmate

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11575918

http://www.w3.org/2001/XMLSchema#string

P6179

1013262824

http://www.w3.org/2001/XMLSchema#string

P698

11781646

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

phase II clinical trial

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.

about

P2860

P2860

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P921